CLDN1 and Alzheimer disease: Based on whole-exome sequencing (WES) mutations of FLG2 (22, 23), RPTN (24), and CLDN1 (Claudin 1) (25, 26) have been identified to be associated with susceptibility to AD in patients of non-European descent.